Search Results - "Moez, Elloumi"

Assessment of molecular response to tyrosine kinase inhibitors in Tunisian Patients with Chronic Myeloid Leukemia by Frikha, Rim, Kassar, Olfa, Elloumi, Moez, Kamoun, Hassen

“…Aim This study was carried out to assess the minimal residual disease in Tunisian patients with chronic myeloid leukemia (CML) treated with tyrosine kinase…”
Get full text

MTHFR 677T-1298C haplotype in acute lymphoblastic leukemia: Impact on methotrexate therapy by Frikha, Rim, Elloumi, Moez, Rebai, Tarek, Kamoun, Hassen

“…Introduction Functional variants of the Methylenetetrahydrofolate reductase (MTHFR) gene, the C677T and A1298C, have largely investigated in pharmacogenomics…”
Get full text

DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN TUNISIAN CHRONIC MYELOID LEUKEMIA PATIENTS by Rim FRIKHA, Moez ELLOUMI, Hassen KAMOUN

“…Objective: Some patients who achieve deep molecular remission (DMR) can successfully discontinue tyrosine kinase inhibitors (TKI). TKI discontinuation in…”
Get full text

Impact of CYP1A1 variants on the risk of acute lymphoblastic leukemia: evidence from an updated meta-analysis by Frikha, Imen, Frikha, Rim, Medhaffer, Moez, Charfi, Hanen, Turki, Fatma, Elloumi, Moez

“…Objective Our study aimed to investigate the association between cytochrome P450 1A1 ( CYP1A1 ) polymorphisms (T3801C and A2455G) and acute lymphoblastic…”
Get full text

Imatinib mesylate-induced acute hepatotoxicity by Frikha, Imen, Fakhfakh, Yousra, Sahnoun, Rim, Chtourou, Lassaad, Medhaffar, Moez, Elloumi, Moez

“…Introduction Imatinib is a first-line selective tyrosine kinase inhibitor used for the treatment of chronic myeloid leukemia. Although imatinib-induced…”
Get full text

Co-existence of BCR-ABL and JAK2V617F mutation in resistant chronic myeloid leukemia in the imatinib era: Is there a correlation? by Frikha, Rim, Turki, Fatma, Kassar, Olfa, Elloumi, Moez, Kamoun, Hassen

“…Introduction Diagnoses of myeloproliferative disorder is based on molecular marker. Chronic Myeloid Leukemia and Myeloproliferative neoplasms were considered…”
Get full text

Non-Hodgkin's lymphoma developed during imatinib mesylate treatment of chronic myeloid leukemia by Kassar, Olfa, Kahla, Aicha Ben, Koubaa, Asma, Kallel, Faten, Amor, Imen Ben, Elloumi, Moez

“…Introduction Non-Hodgkin lymphoma induced by imatinib, as a tyrosine kinase inhibitor, is a rare complication. Case report A 54-year-old female with a history…”
Get full text

Life threatening hepatotoxicity induced by Nilotinib by Khelifa, Latifa, Ben Amor, Imen, Kassar, Olfa, Mdhaffer, Moez, Hdiji, Sondes, Elloumi, Moez

“…Introduction Tyrosine kinase inhibitor had changed the prognosis of chronic myeloid leukemia (CML) and the overall survival had reached 95%. Unfortunately,…”
Get full text

Investigation of Azole Resistance Involving cyp51A and cyp51B Genes in Clinical Aspergillus flavus Isolates by Ghorbel, Dhoha, Amouri, Imen, Khemekhem, Nahed, Neji, Sourour, Trabelsi, Houaida, Elloumi, Moez, Sellami, Hayet, Makni, Fattouma, Ayadi, Ali, Hadrich, Ines

“…This study aimed to investigate azole resistance mechanisms in Aspergillus flavus, which involve cyp51A and cyp51B genes. Real-time Reverse Transcriptase qPCR…”
Get full text

Assessment of peripheral blood CD26+ leukemic stem cells in CML Patients : a preliminary study by Frikha, Rim, Turki, Fatma, Louati, Nour, Elloumi, Moez, Kamoun, Hassen

Get full text

Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia by Kallel, Faten, Kassar, Olfa, Maaloul, Imen, Charfi, Maha, Ksouda, Kamilia, Elloumi, Moez

“…Introduction Pulmonary toxicity causally related to Imatinib (IM) therapy is uncommon in patients with chronic myeloid leukemia. Case report A 61-year-old…”
Get full text

Aplastic anemia secondary to tyrosine kinase inhibitor therapy in a patient with chronic myeloid leukemia by Kassar, Olfa, Mallek, Rahma, Ben Said, Fatma, Kallel, Faten, Ksouda, Kamilia, Khabir, Abdelmajid, Elloumi, Moez

“…Introduction Nilotinib, as the second generation of tyrosine kinase inhibitor, has significant efficacy in patients with chronic myeloid leukemia resistant or…”
Get full text

Involvement of C677T MTHFR variant but not A1298C in methotrexate-induced toxicity in acute lymphoblastic leukemia by Frikha, Rim, Jemaa, Maha Ben, Frikha, Fakher, Turki, Ines, Elloumi, Moez, Keskes, Leila, Kamoun, Hassen, Rebai, Tarek

“…Background Methotrexate (MTX) is a key drug in acute lymphoblastic leukemia (ALL) treatment; it inhibits DNA replication by blocking the conversion of 5, 10…”
Get full text

PB2320: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONG THE ELDERLY: A TUNISIAN MULTICENTER EXPERIENCE by Zahra, Kmira, Belaid, Imtinène, Kacem, Karima, Elloumi, Moez, Mezlini, Amel, Msaddek, Fehmi, Tarek, Ben Othman, Nabil, Toumi, Lakhal, Raihane Ben, Khelif, Abderrahim, Slim, Ben Ahmed, Afef, Khanfir, Laatiri, Adnene

Get full text

PB1891: EARLY DEATH IN ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA by Koubaa, Asma, Kassar, Olfa, Charfi, Maha, Derbel, Yousra Fakhfakh, Kallel, Faten, Frikha, Imen, Amor, Imen Ben, Khalifa, Latifa, Mallek, Rahma, Medhaffar, Moez, Hdiji, Sondes, Elloumi, Moez

Get full text

PB2367: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH NODAL PERIPHERAL T‐CELL LYMPHOMA by Yahia, Noura Ben, Charfi, Maha, Kallel, Faten, Amor, Imen Ben, Derbel, Yousra Fakhfakh, Frikha, Imen, Latifa, Khelifa, Medhaffar, Moez, Kassar, Olfa, Mseddi, Sondes Hadiji, Elloumi, Moez

Get full text

PB2650: ALLOANTIBODIES IN VON WILLEBRAND DISEASE: ABOUT 6 CASES IN SOUTHERN TUNISIA by Chalbaoui, Amal, Mallek, Rahma, Megdiche, Fatma, Kallel, Faten, Krichen, Imen, Hdiji, Sondes, Kassar, Olfa, Frikha, Imen, Charfi, Maha, Amor, Imen Ben, Fakhfekh, Yosra, Khelifa, Latifa, Moez, Medhaffar, Kallel, Choumous, Elloumi, Moez

Get full text

PB2369: PERIPHERAL T CELL LYMPHOMA: EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS by Charfi, Maha, Yahia, Noura Ben, Kallel, Faten, Frikha, Imen, Derbel, Yousra Fakhfakh, Kassar, Olfa, Amor, Imen Ben, Latifa, Khelifa, Mseddi, Sondes Hadiji, Medhaffar, Moez, Elloumi, Moez

Get full text

PB1749: COMPARATIVE STUDY OF B AND T‐ALL IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS: CLINICAL CHARACTERISTICS AND THERAPEUTIC RESULTS by Frikha, Imen, Kahla, Aicha Ben, Medhaffer, Moez, Louati, Nour, Amor, Imen Ben, Kassar, Olfa, Khalifa, Latifa, Charfi, Maha, Kallel, Faten, Mallek, Rahma, Hdijji, Sondes, Amor, Ikram Ben, Mnif, Hela, Elloumi, Moez

Get full text

PB2020: OUTCOMES OF PATIENTS WITH HIGH RISK MYELODYSPLASTIC SYNDROMES by Amor, Imen Ben, Charfi, Maha, Mdhaffar, Moez, Abdejlil, Nour Ben, Kallel, Faten, Fakhfekh, Yosra, Khelifa, Latifa, Mallek, Rahma, Frikha, Imen, Elloumi, Moez

Get full text